1-7 of 7
Miho Minami
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retention of Slow-Cycling CD34 + cells During Imatinib Treatment and Rapid Decline After 2nd ABL-TKI Treatment in Ph + Leukemia Cells

Yosuke Minami, MD, PhD, Akihiro Abe, Miho Minami, Yachiyo Kuwatsuka, Nobuaki Fukushima, Kunio Kitamura, Junji Hiraga, MD, PhD, Kazuhito Yamamoto, MD, PhD, Catriona Jamieson, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 641.
https://doi.org/10.1182/blood.V118.21.641.641
Published: 2011
Journal Articles

Treatment with the PI3K/mTOR Inhibitor, NVP-BEZ235, Overcomes Resistance to Imatinib in Quiescent or T315I-Mutated Ph + Leukemia Cells,

Yosuke Minami, MD, PhD, Miho Minami, Nobuaki Fukushima, Yachiyo Kuwatsuka, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3488.
https://doi.org/10.1182/blood.V118.21.3488.3488
Published: 2011
Journal Articles

Treatment with mTOR Inhibitor, Everolimus (RAD001) Overcomes Resistance to Imatinib In Ph-Leukemia Quiescent Cells.

Yachiyo Kuwatsuka, MD, Yosuke Minami, MD, PhD, Miho Minami, Ryohei Tanizaki, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1579.
https://doi.org/10.1182/blood.V116.21.1579.1579
Published: 2010
Journal Articles

Biomarkers In Cell Death of Imatinib-Resistant Ph-Leukemia Cells During Treatment with mTOR Inhibitor, Everolimus

Miho Minami, Yosuke Minami, MD, PhD, Yachiyo Kuwatsuka, MD, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3988.
https://doi.org/10.1182/blood.V116.21.3988.3988
Published: 2010
Journal Articles

Rapid Reduction of Chronic Myeloid Leukemia Stem Cells After Treatment with Second-Generation BCR-ABL Kinase Inhibitors, Dasatinib and Nilotinib

Yosuke Minami, MD, PhD, Akihiro Abe, Yuka Nomura, Miho Minami, Yachiyo Kuwatsuka, Kunio Kitamura, Junji Hiraga, Shinichi Mizuno, Kazuhito Yamamoto, Tomohiro Kajiguchi, Masashi Sawa, Yuichiro Inagaki, Toshiya Yokozawa, Etsuko Aoki, Kazutaka Ozeki, Keisuke Watanabe, Koichi Miyamura, Hitoshi Kiyoi, Tomoki Naoe
Journal: Blood
Blood (2010) 116 (21): 4457.
https://doi.org/10.1182/blood.V116.21.4457.4457
Published: 2010
Journal Articles

Treatment with mTOR Inhibitor, Everolimus (RAD001) Overcomes Resistance to Imatinib in Ph-Leukemia Quiescent or T315I-Mutated Cells.

Yosuke Minami, MD, PhD, Miho Minami, Yachiyo Kuwatsuka, MD, Ryohei Tanizaki, MS, Yuka Nomura, Akihiro Abe, MD, PhD, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3277.
https://doi.org/10.1182/blood.V114.22.3277.3277
Published: 2009
Journal Articles

Treatment with Bortezomib Overcomes Resistance to Imatinib in Ph-Leukemia Quiescent Cells.

Yachiyo Kuwatsuka, MD, Yosuke Minami, MD, PhD, Ryohei Tanizaki, MS, Miho Minami, Akihiro Abe, MD, PhD, Yuka Nomura, Hitoshi Kiyoi, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1426.
https://doi.org/10.1182/blood.V114.22.1426.1426
Published: 2009